Latest Industry Insights
Industry Insight
Identifying Risk Factors for Long COVID With Single-Cell Proteomics
In this interview we speak to Sean Mackay, CEO of IsoPlexis, to discuss how single-cell functional proteomics have helped researchers understand the risk factors behind long COVID.
Industry Insight
A Landscape Assessment of Newborn Screening in Europe
This industry insight explores the findings from a comparative analysis of specific policies governing periodic updates to NBS panels in 30 European countries.
Industry Insight
The Bright Future of mRNA
Technology Networks interviewed Frank DeRosa, chief technology officer and head of research at the mRNA Center of Excellence, Sanofi, to discuss the “bright future” of mRNA platforms.
Industry Insight
Developing Chicken-Free Egg Whites
Cellular agriculture could provide a more sustainable way to meet the demand for eggs. We spoke to Maija Itkonen, CEO of Onego Bio, to find out more about their chicken-free egg white.
Industry Insight
Time for Proteomics To Shine
Technology Networks had the pleasure of interviewing Dr. Oliver Rinner, CEO at Biognosys, to learn more about some of the recent developments in proteomics, and discuss what the future could hold for the field.
Industry Insight
Driving Progress in Personalized Cancer Therapy
Personalized medicine has the potential to change the cancer patient's journey by predicting how they will respond to different treatments. Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to find out more!
Industry Insight
CRACKing the Brain’s Cellular Code: An Interview With Professor Jerry Chen
Unpicking our brain's complexity at a cellular level is a mammoth task. How do our genes, cells and electrical impulses come together to decode the world around us? At Boston University Assistant Professor Jerry Chen is trying to crack this code. In this interview, we speak to Chen about his study’s aims, findings and implications.
Industry Insight
Measuring Lipids in the Blood Can Predict Disease Risk Decades Before Onset
A new study demonstrated that lipidomic profiling can be used to predict the risk of developing Type 2 diabetes (T2D) and cardiovascular disease (CVD) years before disease onset. We spoke with study lead Professor Chris Lauber to find out more.
Industry Insight
Effective Diagnostics for Liver Disease Are Urgently Needed
As primary care physicians continue to see an increasing number of patients with fatty liver disease, it is important for them to be able to effectively triage these patients to ensure the best possible care. In this opinion piece, Dr. Tram Tran, Chief Medical Officer of Glympse, discusses the importance of early intervention and highlights the urgent need for effective diagnostic strategies.
Industry Insight
Women in Science: Perspectives From Industry
In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.
Advertisement